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The Terebridae and teretoxins: Combining
phylogeny and anatomy for concerted discovery
of bioactive compounds
Nicolas Puillandre1, Mandë Holford2*
Abstract
The Conoidea superfamily, comprised of cone snails, terebrids, and turrids, is an exceptionally promising group for
the discovery of natural peptide toxins. The potential of conoidean toxins has been realized with the distribution of
the first Conus (cone snail) drug, Prialt (ziconotide), an analgesic used to alleviate chronic pain in HIV and cancer
patients. Cone snail toxins (conotoxins) are highly variable, a consequence of a high mutation rate associated to
duplication events and positive selection. As Conus and terebrids diverged in the early Paleocene, the toxins from
terebrids (teretoxins) may demonstrate highly divergent and unique functionalities. Recent analyses of the Terebri-
dae, a largely distributed family with more than 300 described species, indicate they have evolutionary and phar-
macological potential. Based on a three gene (COI, 12S and 16S) molecular phylogeny, including ~50 species from
the West-Pacific, five main terebrid lineages were discriminated: two of these lineages independently lost their
venom apparatus, and one venomous lineage was previously unknown. Knowing the phylogenetic relationships
within the Terebridae aids in effectively targeting divergent lineages with novel peptide toxins. Preliminary results
indicate that teretoxins are similar in structure and composition to conotoxins, suggesting teretoxins are an attrac-
tive line of research to discover and develop new therapeutics that target ion channels and receptors. Using cono-
toxins as a guideline, and innovative natural products discovery strategies, such as the Concerted Discovery
Strategy, the potential of the Terebridae and their toxins are explored as a pioneering pharmacological resource.
Introduction
The conoideans (cone snails, terebrids, and turrids) are
a hyperdiverse group of marine gastropods that prey on
fish, worms, and other mollusks (Figure 1). Several con-
oidean lineages are characterized by specialized organs
referred to as a venom apparatus that is used to subdue
prey [1]. Analysis over the last three decades of venom
toxins produced by various species in the genus Conus
(cone snails), the most famous representative of this
group, reveal a complex system of molecular com-
pounds (see e.g. [2,3]). Each Conus species is able to
produce 100-200 peptide toxins [4,5], making this
genus, and by extension the whole Conoidea superfam-
ily, one of the most promising groups for the discovery
of natural peptide toxins together with snakes, spiders
and scorpions.
Within the conoideans, the auger snails, or the Tereb-
ridae, include approximately 300 to 350 described spe-
cies [6,7]. The Terebridae, characterized by an elongated
shell, are mostly sand-dwellers that live in shallow-
waters near the tropics. Contrary to cone snails, tereb-
rids have not attracted significant scientific attention,
and comparatively little is known about their ecology
and toxinology. Most of the main lineages of conoi-
deans, including terebrids and conids, diverged at least
in the early Paleocene [8]. Such an early separation
would indicate toxins from terebrids could be highly
divergent and unique, compare to toxins found in the
genus Conus.
Presented here is an overview of the emerging poten-
tial of terebrids and their peptide toxins. As terebrid
toxins are closely related to cone snail toxins (conotox-
ins), what is known about the structural and functional
diversity of conotoxins, and their application in pharma-
cology is first briefly reviewed. In addition, a comparison
will be made of the traditional biochemical approach to
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peptide toxin discovery, and a novel multidisciplinary
biodiversity first approach, termed the Concerted Discov-
ery Strategy (CDS). CDS combines molecular and che-
mical techniques with phylogenetic analysis of species
and toxin evolution to enhance the discovery of peptidic
natural products. Recent results highlight the advantage
of CDS to quickly define independent lineages within
Conus [9,10] and the terebrids [11,12], thus facilitating
the identification of numerous and divergent species,
each producing unique peptide toxins. By analogy with
“conotoxin”, the term “teretoxin” is introduced to desig-
nate natural peptide toxins produced by terebrid snails.
1. Conotoxins and pharmacology
1.1. Brief history of the discovery of conotoxins
Cone snails were known as venomous predators [13] for
many years before the analysis of their venom started in
the 1970’s, with the isolation of active compounds from
the venom gland of C. californicus [14] and C. geogra-
phus [15]. In 1981, Gray et al.[16] first biochemically
described the structure and function of several conotox-
ins extracted from C. geographus. Soon after, the Oli-
vera group identified numerous toxins from other
Conus species, such as C. magus, C. striatus, and C. tex-
tile [17,18]. In the following two decades, the regularity
of toxin discovery has been enhanced both by the num-
ber of laboratories working on conotoxins, and by the
use of new techniques that improved characterization
methods such as molecular biology, mass spectrometry,
and sequencing. Currently there are more than 3,000
different proteins extracted from Conus venom
described (Conoserver: http://research1t.imb.uq.edu.au/
conoserver/).
1. 2. Structure and function of conotoxins
The vast majority of conotoxins are characterized by a
three-domain structure consisting of: a highly conserved
signal sequence, a more variable pro-region and a hyper-
variable mature sequence (Figure 2A). The signal
sequence can be used as a diagnostic character to attri-
bute each conotoxin to one of the ~15 superfamilies
described so far (Figure 2B). The mature toxin is a dis-
ulfide-rich peptide with a highly conserved cysteine pat-
tern in each superfamily [5] (Figure 3). At least
25 different functions have been described for a small
fraction of the known conotoxins that have been charac-
terized ([5]; conoserver). By the end of the 1990’s, given
the diversity of their molecular targets such as, sodium
(Na+), potassium (K+) or calcium (Ca2+) channels, nora-
drenaline transporter, and nicotinic acetylcholine
(nACh) receptors, it became apparent conotoxins pos-
sessed potentially numerous therapeutic applications.
1.3 The emergence of conotoxins for drug development
The first conotoxin to be approved for use as a drug is
ziconotide (Prialt), which is used to treat chronic pain in
HIV and Cancer patients [19]. Ziconotide was discov-
ered and developed from the ω -MVIIA peptide
expressed by Conus magus (Figure 3). As other ω cono-
peptides of the O superfamily, MVIIA targets Ca2+
channels and has high specificity for the N-type calcium
channel CaV2.2. The emergence of ziconotide has led to
Figure 1 Evolution of Conoidea classification. Cone snail, turrid, and terebrid shells that make up the Conoidean superfamily are depicted. A.
Conoidea classification based on shell and radula characters (e.g. [8,57]). B. Conoidea classification based mainly on anatomical characters ([1]).
ST = Strictispiridae; DR = Drilliidae; PS = Pseudomelatomidae. C. Conoidea classification with molecular characters. Two main clades are defined,
but a formal classification has not yet been proposed.
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the increased investigation of cone snail peptides in drug
development. This is in large part due to the large num-
ber of conotoxins discovered and their specificity for
particular ion channels and receptors. A recent review
[5], listed several conotoxin-derived peptides that
reached clinical development at various stages. These
include: Contulakin-G (neurotensin receptor), c -MrIA
(norepinephrine transporter), a-Vc1.1 (nicotinic
receptors), Conantokin-G (NMDA receptors), -PVIIA
(K+ channels), and μO-MrVIB (Na+ channels). Most of
the contoxins listed are potential therapeutics for pain,
but several are being evaluated for epilepsy or myocar-
dial infraction. Twede et al. [20] also cited several other
conotoxins with neuroprotective/cardioprotective prop-
erties: namely, conantokins, ω, μ and -conotoxins that
respectively target NMDA receptors, Ca2+, Na+ and K+
Figure 2 Molecular organization of Conoidean venom toxins. A. Schematic of the precursor sequence for conoidean toxins. Conoidean
toxins possess a signal sequence at the ntermini, an intervening pro-region, followed by the mature toxin in single copy. Each gene superfamily
is generally characterized by one highly conserved signal sequence, associated in most cases to one cysteine (Cys)-pattern in the mature
sequence, and corresponding to several toxin families (such as a, μ, ω, δ) and molecular targets (ion channels or receptors). B. Conotoxin
examples. Depicted are the mature toxin sequences, gene superfamily, and molecular targets of well characterized conotoxins.
Figure 3 Cysteine scaffold of conotoxins. Representative disulfide connectivity of three conotoxins belonging to three different gene
superfamilies are illustrated.
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channels. It should be noted that although ziconotide is
a breakthrough, delivery of the drug by intrathecal injec-
tion is problematic and limits its utility.
2. Conus: the tree that hides the forest
2.1. Conoidean phylogeny
Conus and the Terebridae both belong to the superfam-
ily Conoidea. This group has always been considered a
taxonomic nightmare, primarily because of its substan-
tial diversity, 4,000 described species, with an estimate
of more than 10,000 living species [21], and secondarily
because of the difficulty to propose a stable system of
classification [22]. Very few classifications have been
proposed, however most of them are not congruent, and
are largely contradictory. Conoidean classification has
evolved in accordance with the character type used to
delimit groups. Initially, only shell and radula characters
were used. As they are beautifully ornamented and
easily distinguished, cone snails are the most famous
conoideans, a star among shell collectors, taxonomists,
and biochemists alike. Consequently, cone snails were
classified in a separate family, the Conidae. Similarly,
the Terebridae, with their thin, elongated shells, are
relatively easy to recognize, and were also classified as
an independent family. All the others conoideans were
placed in the Turridae s.l. (Figure 1A). More recently,
the analysis of anatomical characters revealed that cone
snails are not so different from other conoideans, and
some turrids (Clathurellinae, Raphitominae, Mangelii-
nae, Oenopotinae, Conorbinae) were placed in the Coni-
dae together with Conus ([1]; Figure 1B). The use of
molecular characters to analyze conoidean classification
gave yet a different structure to the superfamily. Mole-
cular characters confirmed that Turridae s.l. was a lar-
gely paraphyletic group, including Conus, but also
Terebridae [22]. It is clear that more interdisciplinary
research that combines molecular, anatomical and mor-
phological characters is needed to establish a valid clas-
sification of the Conoidea.
2.2. The revolution of molecular phylogeny as it pertains
to Conoideans
The advent of the polymerase chain reaction (PCR) and
sequencing has revolutionized taxonomic classification.
Together with anatomical and morphological characters,
molecular approaches help to define distinct biodiverse
groups. Molecular approaches identified at least 15 inde-
pendent lineages within the conoideans, most of them
corresponding to previously recognized taxa [1,8,22,23].
Some taxa were traditionally recognized as families, i.e.
Conus as Conidae, while others were considered as sub-
families, i.e. Mangeliinae, and Crassispirinae. Molecular
results suggest that the genus Conus does not have a
central position in the superfamily, but rather it
corresponds to one lineage among others. Even if cone
snails remain the most collected and studied group
within Conoideans, terebrids and turrids are a compel-
ling research source as they may have evolved unique
and diverse venom toxins. Preliminary analyzes of turri-
toxins [24,25] and teretoxins [26,27] are promising
(Table 1).
Consider for a moment, if 3,000 conotoxins are
already described, how many peptide toxins can be
expected for the whole conoideans? How can such
diversity be embraced, and how can peptide toxin dis-
covery be optimized? In the next two sections, an esti-
mation of peptide toxin diversity is proposed to answer
the first question, and a new strategy, termed “Con-
certed Discovery Strategy (CDS),” is described to handle
the second.
2.3. A sizeable natural library of peptide toxins
It has been shown that each Conus species can express
between 100 and 200 different peptide toxins, most
being exclusive, i.e. not found in any other species. With
more than 600 described species, and others remaining
to be discovered, it can estimated that 60,000 to 120,000
different peptide toxins could be produced by cone
snails. These numbers are probably underestimated, as
unpublished results (F. Ducancel et al., A. Lluisma and
P. Bandyopadhyay) indicate that a single species may
include 200 different toxins, only for the A-superfamily.
Preliminary results obtained for terebrids and turrids
seem to indicate that similar levels of toxin diversity
occur in these two groups as well [24-29] (Figure 4).
Based on these conclusions, it is possible to estimate
that the whole Conoidean superfamily could contain
between 400,000 and 2,000,000 different toxins. Spiders
are the only other venomous group thought to include
similar levels of toxin diversity [30]. Conoideans are
thus producing a sizeable natural library of peptide tox-
ins that have potential applications for biomedical appli-
cations and drug development.
2.4. A concerted discovery strategy for finding new
peptide toxins
As applied since the beginning of the 1980’s, the tradi-
tional process of toxin discovery is to fractionate the
crude venom from a target species, then characterize
the fractions using Edman sequencing or electrospray
ionization mass spectrometry (ESI-MS/MS) (Figure 5A).
Most of the species that have been studied with this
method correspond to species that are easy to collect,
large enough to allow an easy extraction of the venom
in a sufficient quantity, and known to be highly veno-
mous, especially for vertebrate preys. These features
were thought to indicate toxins viable for therapeutic
applications in humans. While overwhelmingly used by
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most researchers, the traditional strategy has several
drawbacks, such as it is extremely laborious and requires
large amounts of material to be successful. Several find-
ings from the work of the Olivera group [31,32] in the
1990’s elucidated the molecular structure of conotoxins
(Figure 2). Namely, the conserved signaling region of
the peptide toxin gene superfamilies has enabled the use
of PCR and other molecular techniques to minimize the
identification of toxins using the traditional strategy.
However, in cases where a significant amount of sample
material is not available, use of the traditional strategy is
a challenge.
The Concerted Discovery Strategy (CDS), previously
referred to as the exogenomic strategy as proposed by
Olivera [5], differs from the traditional toxin discovery
strategy in the way species and venom compounds are
selected (Figure 5B). With CDS, species are not chosen
based on technical criteria, such as size and ease of col-
lection, but using an evolutionary-based approach. The
central idea is to identify species that belong to highly
divergent lineages, thus potentially able to express
highly divergent toxins. This method enhances the
probability of characterizing different toxins. A larger
pool of different toxins increases the likelihood of iden-
tifying those with different molecular targets, indicating
different therapeutic applications. Compared to the tra-
ditional strategy, where most of the studied species
belonged to a limited number of clades within Conus,
suggesting a biased estimation of the peptide toxin
diversity within the genus, CDS is much more aligned
with identifying a diverse set of peptide toxins with
diverse functional applications. Furthermore, a biodiver-
sity first concerted method will allow the identification
of the lineages that have lost the venom apparatus
Table 1 Recently identified teretoxins
Teretoxin Mature Toxin Sequence Corresponding conotoxin Superfamily Potential Target
Agx-s11a DCEQHTDCSAASGPVYCCQDSDCCGGVDYICTNYGQCVRHF I K+ channels
Agx-s6a SLDEELKSNDCPEYCPHGNECCEHHECRYDPWSRELKCLDSLDS O Na+, K+, Ca2+ Channels
Agx-s7a ATNRHQCDTNDDCEEDECCVLVGGNVNNPGVQTRICLACS O Na+, K+, Ca2+ Channels
Hhe6.3 VLFTPPELLGCGNRCSDDCCKWGRCQPGCTD O Na+, K+, Ca2+ Channels
Hhe9.1 YEENCGTEYCTSKIGCPGRCVCKEYNYNGEITRRCRA P Unknown
Hhe9.2 DEEVGCFPNVCKNDGNCSIETSTGMTRCQCLEGYTGHVCENPL P Unknown
Figure 4 Comparison of the known number of toxins (left) and species (right) in the main groups of the Conoidea. The number of
toxins in Conidae ("conotoxins”) corresponds to the published toxins in GenBank. No turritoxins or teretoxins are published in GenBank, but
several were recently described ([24-29]).
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within the Conoideans, a not-so-rare feature in this
group (see Sect. 4.2.2, but also [1,33,34]; Fedosov and
Puillandre unpublished data). A priori knowledge about
the presence or absence of a venom apparatus elimi-
nates the expense of time and resources pursuing speci-
mens without venom ducts, hence not expressing
peptide toxins to hunt prey.
Another feature of CDS makes use of the advances of
molecular biology in the form of manufacturing cDNA
or EST libraries. Using cDNA libraries of venom duct
tissue, expressed gene products are analyzed, and poten-
tial peptide toxin are identified. At this stage, a phyloge-
netic approach can be used to analyze the toxin
diversity within a single species. Recent studies have
Figure 5 Toxin discovery process. A. Traditional strategy. Analyzed species are chosen randomly, and may correspond to a single lineage.
Prospective toxin analysis starts first with characterization of venom components by HPLC (venom fractionation). B. Concerted Discovery Strategy
(CDS). Taxonomic tools are used first to identify independent lineages to maximize the species, and thus teretoxin diversity, and then to analyze
the numerous cDNA compounds isolated from each analyzed specimen. Application of CDS increases discovery of divergent teretoxins.
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shown that divergent clades within a toxin-based phylo-
geny may produce toxins with different functions (e.g.
[2,9,10,35]). Instead of functionally analyzing randomly-
chosen toxins, as in the traditional method, CDS high-
lights promising toxins to be screened first. Using CDS,
phylogenetic methods are used to identify prospective
targets, first species within conoideans and then toxins
within the selected species.
3. The Terebridae family
3.1. Traditional taxonomy of the Terebridae
The Terebridae was first identified and classified by Bru-
guiere (1789), who created the genus Terebra. Since that
time the seminal works to classify the group have been
presented in recent papers highlighting the anatomy and
shell morphology [7,36-38]. Miller in his publications in
the 1970’s plucked the group from relative obscurity to
highlight the fascinating degree of anatomical variability
that accounts for the diverse feeding strategies within
the Terebridae. Based on analysis of foregut materials
Miller identified three different types of terebrid anat-
omy: (1) Type I has salivary glands, a shrunken buccal
tube, no radula sac, venom duct, or venom bulb. (2)
Type II has the venom apparatus similar to Conus, i.e. a
radular sac, venom duct and venom bulb, in addition to
salivary glands and a true proboscis. (3) Type III lacks
salivary glands and the components of the venom appa-
ratus, but has an uncharacteristic accessory feeding
organ, the accessory proboscis structure. Using speci-
mens from the genera Duplicaria, Taylor has revised
terebrid foregut anatomy based on radula characteristics
and identified an amendum to Miller’s Type I that has
salivary glands and a radula sac, but no venom gland
[37]. Based on shell morphology, Bratcher and Cerno-
horsky [7], and more recently Terryn [6] have identified
~300 different species within the Terebridae. Bratcher
and Cernohorsky placed the species into four genera: a
large genus termed Terebra, consisting of the majority
of species, a second genus termed Hastula, a third
genus termed Duplicaria, and a fourth termed Tere-
nolla. Terryn in his classification made use of ~15 gen-
era terms, including Myurella, and Cinguloterebra. The
first phylogeny of the group was done by Taylor et al.
[1]. Using seven species of Terebrinae and seven of Per-
vicaciinae, Taylor and colleagues outlined anatomical
terminology for the terebrid foregut and postulated a
phylogeny that identified the Terebridae as monophy-
letic and separate from the Conidae.
Simone in 2000 [39] updated the terebrid phylogeny
using specimens from the Western Atlantic. Simone
confirmed the monophyly of the group, identified the
Hastula genera as separate from the genus Terebra and
found the following apomorphies: reduction of the
cephalic tentacles, anterior end of the ctenidial vein
prominent (without gill filaments), rhynchodcal intro-
vert, and anus situated very posteriorly in the pallial cav-
ity. Bouchet and Rocroi [40] in the most recent
classification based on morphology of the Gastropoda
confirmed the presence of two subfamilies, Terebrinae
and Pervicaciinae, within the family Terebridae. The use
of anatomy, and shell characteristics were sufficient to
elucidate the monophyly of the Terebridae, but for defi-
nitive delimitations at genera and species level, an inte-
grative approach using molecular biology is required.
3.2. Molecular Phylogeny applied to the Terebridae
The revisionary process that resulted from the use of
molecular characters for the Conoideans classification
also happened for the Terebridae. Most of the genera
recognized by Terryn [6] do not correspond to clades,
as defined by molecular analyzes based on 16S, 12S, and
COI mitochondrial genes and ~50 different species
[11,12]. Molecular analysis identified five distinct clades
in the Terebridae: a sister group to all other terebrids
made up of T. jungi, since revised to the genus Pellifro-
nia [41] (clade A), an Acus clade (clade B), a Terebra
clade (clade C), a Hastula clade (clade D), and a Myur-
ella clade (clade E) (Figure 6). This result indicates that
most of the morphological characters used to define
genus-level groups of terebrids should be used with cau-
tion, and could correspond to convergent evolution or
ancestral polymorphism. The genus “Terebra“ is a good
illustration of the conflict between classical morphologi-
cal characters and molecular data. Specimens morpholo-
gically attributed to this genus are found in three
different clades: Pellifronia, Terebra, and Myurella as
identified by Holford et al. [11,12].
In addition to the clarification of the phylogenetic
relationships within the Terebridae, the tree outlined in
Figure 6 provides a reliable framework to analyze the
evolution of different terebrid characters (see Sect. 4).
3.3. Alpha-taxonomy of the Terebridae
As stated above, the only available molecular work on
terebrids highlighted several complications at the gen-
eric level, and also revealed that the alpha-taxonomy
(species delimitation and description) may need to be
revised [12]. Based on shell characters only, the defini-
tion of species in the Terebridae certainly suffers from
the same pitfalls cited previously for the classification:
morphological convergence or ancestral polymorphism.
Furthermore, the molluscan shell is known to be highly
plastic, and morphological variation may only be the
results of environmental variability within a single spe-
cies range [42]. The results presented in Holford et al.
[12] indicate that some species correspond to several
lineages (e.g. Strioterebrum plumbeum, Cinguloterebra
fenestrata), and that several molecularly defined lineages
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are not named at the species level (e.g. the “Terebra“
textilis complex). However, the sampling used in this
study does not allow a clear analysis of the species-level
variability within the terebrids. More specimens are
required to estimate both the intra and inter-specific
variability of each putative species, in order to propose
robust hypotheses of species delimitation.
Several recent expeditions carried out in the Indo-
West Pacific by the Muséum National d’Histoire Natur-
elle (Paris) uncovered a large number of specimens,
representing both already described species and several
unknown taxa. Recently, four different Terebridae spe-
cies were collected during an expedition in the East
Pacific (Panama) [11]. Two of these four species were
represented by several specimens, and the results are
congruent with the morphological hypotheses: the mole-
cular variability within species is weaker than the varia-
bility between species.
3.4 Terebrid ecology and behavior
Miller [43] provided the most detail known to date on
the feeding ecology of the terebrids. Miller described
three anatomical feeding varieties (Types I, II, and III)
only one of which (Type II) possessed the venom appa-
ratus similar to that used by Conus. The terebrid clades
that have a venom apparatus correspond to three diver-
gent lineages, implying the three clades with a venom
apparatus (Pellifronia, Terebra, and Hastula) may have
evolved different feeding strategy (Figure 6). Further-
more, the two other terebrid lineages that have lost the
venom duct, Types I and III, while not good candidates
to find new teretoxins, are good models to analyze the
ecological adaptation of venom-apparatus free conoi-
deans. Questions to be investigated include, how do spe-
cies that lack the venom duct and radula, which are the
main characteristics for capturing prey using venom tox-
ins, feed? Are they still able to capture prey using toxins
produced by other glands (e.g. the salivary gland), or did
they develop new strategies not based on venom? If so,
did the two lineages without the venom ducts develop
similar or different strategies? Preliminary work in
Conus has demonstrated that peptide toxins are pro-
duced in the salivary glands [44], suggesting it may be
possible that the Type I species of terebrid, which lack a
Figure 6 Molecular phylogeny of the Terebridae. Five clades are defined Pellifronia, Acus, Terebra, Hastula, and Myurella (Clades A to E). Two
clades have lost the venom apparatus: Acus (clade B) and Myurella (clade E), corresponding to two independent losses (red stars). Two lineages
are found in the Panamic Eastern Pacific, black arrows correspond to Acus strigata and Terebra arygosia, the others in the Western Pacific. The
tree was constructed using Bayesian and likelihood analyzes based on COI, 12S and 16S mitochondrial genes, see [11,12] for full details on the
molecular phylogeny. The molecular phylogeny of the Terebridae effectively highlights the terebrid lineages that have a venom apparatus
(Pellifronia, Terebra, Hastula), therefore using peptide toxins to subdue prey, and those that do not have a venom apparatus (Acus, Myurella), thus
not using toxins to hunt.
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venom apparatus, but have salivary glands, could also
use toxins to subdue its prey. The delivery of the toxins
is not clear as most Type I species do not have a radular
or a true proboscis to deliver the toxin to the prey. Type
III terebrids have developed an accessory feeding organ
that they use to engulf polychaetes and other worms.
There are many open questions pertaining to the ecol-
ogy of the terebrids. These could be addressed in tan-
dem with studies involving the evolutionary
development of the venom apparatus. Of the three
Miller types which is the ancestral one that led to the
development of the others? The radula is often hailed as
the component responsible for the radiation of species
diversity in Conus [45], could it also explain diversity in
Type II terebrids? Given the complications of breeding
terebrids and the complexity of the venom apparatus,
evolutionary development questions might be difficult to
approach using embryology and current evo-devo tech-
niques, but highlight an interesting line of research that
would enhance current knowledge about the terebridae
and evolutionary/ecological development in general.
3.5 Evolution of venom apparatus as it pertains to
peptide toxins in the Terebridae
One striking result of the molecular phylogenetic analy-
sis of the Terebridae is that the venom apparatus
appears to have been lost at least twice independently
during the evolution of the group (Figure 6). The corol-
lary finding is that the venom duct was present in the
common ancestor of all the terebrids, and also in the
common ancestor of all the conoideans [1]. From this
common ancestor, three highly divergent lineages
evolved independently in the Terebridae: Pellifronia,
Terebra and Hastula. As these lineages correspond to
deep nodes in the tree, and given the extremely high
rate of evolution of the toxins in the genus Conus [2,3],
these terebrids may have evolved different toxins. The
conotoxins discovered so far belong to ~ 15 different
superfamilies, and evolved ~ 25 different functions;
however, the genetic distance between Pellifronia, Tere-
bra and Hastula within the Terebridae is at least two
times greater than the distance between the different
species of Conus from which the known conotoxins
were extracted (unpublished results). The potential
divergence between teretoxins extracted from species
belonging to different clades suggests previously unde-
scribed superfamilies and functions could be identified
from terebrid characterizations.
3.6 Preliminary characterization of teretoxins
While only a few teretoxins have been described in the
literature, results from preliminary characterizations
indicate their potential as biochemical tools for analyz-
ing the mechanics and function of the neuronal circuit.
Several teretoxins, previously referred to as augertoxins,
identified by Imperial and colleagues [26,27] from Tere-
bra subulata and Hastula hectica have a cysteine frame-
work similar to the O-superfamily of conotoxins (Table
1). This suggests that they may fold into the inhibitory
cysteine knot motif referred to as the ICK motif [46].
The ICK motif is common among peptide toxins from
various organisms including snakes and spiders, and is
known to block ion channels. While the T. subulata ter-
etoxins identified have a similar O-superfamily cysteine
framework, the signal sequence of the precursor region
is not homologous with the conotoxin O-superfamily
signal sequence [26]. This suggests that although the
mature toxins are similar, the genes encoding the pep-
tides are not. Likewise, the teretoxins identified from H.
hectica [27] have cysteine patterns similar to the O and
P conotoxin superfamilies, but their signal sequences are
highly divergent. These findings indicate the genetic
makeup of conus and terebrid toxins are not the same.
It thus follows that newly discovered teretoxins could
have diverse functional applications compared to their
conotoxin counterparts.
4. Taxonomy as a tool for discovery of bioactive
compounds
4.1. Congruence between anatomy and molecular
phylogeny
The strong congruence between anatomy and the mole-
cular phylogeny based on Western Pacific species is
shown in Figure 6. All the species included in the Acus
and Myurella clades do not have a venom apparatus,
therefore, likely not using peptide toxins to hunt prey.
Conversely, all the species included in the three other
clades, Pellifronia, Terebra and Hastula all have the
venom apparatus, as confirmed by the anatomical dis-
section of most of the species included in the dataset
[12]. The correlation between anatomy and molecular
phylogeny was confirmed by the inclusion of several
species collected in the Eastern Pacific. The Panamic
species A. strigata, placed in the Acus clade, does not
have a venom apparatus, while three other Panamic spe-
cies, T. argyosia, T. ornata, and T. formosa, which pos-
sess a venom apparatus, are placed in the Terebra clade
[11]. These results support the premise that the pre-
sence or absence of the venom duct can be inferred by
including a given species in the phylogenetic tree, with-
out dissecting it. From a teretoxin discovery perspective,
the phylogenetic tree would then be an invaluable asset,
capable of readily identifying the lineages with a venom
apparatus and expressing peptide toxins for predation. A
priori identification of terebrids expressing peptide tox-
ins enhances by several orders of magnitude the initial
step of characterizing novel teretoxins. In addition, the
phylogenetic tree could be used to identify divergent
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lineages and enhance discovery of teretoxins with differ-
ent functional applications. Analysis of at least one spe-
cies from each clade with a venom apparatus would be
sufficient to provide a gross estimation of the toxin
diversity of terebrids.
4.2. The importance of a complete Terebridae phylogeny
for teretoxin discovery
The current molecular phylogeny of the Terebridae
[11,12] is not comprehensive. Several genera and biogeo-
graphic regions are not represented in the dataset. As
five lineages are present in the West Pacific, two of them
having lost the venom apparatus, it can be expect that
there are additional lineages in other regions that have
evolved distinct toxins and possible other independent
lineages that have lost the venom apparatus. A complete
terebrid phylogeny would greatly enhance the discovery
and characterization of novel teretoxins. Current studies
are under way to sample more of the Eastern Pacific and
other regions to encounter the missing taxa.
The Concerted Discovery Strategy (CDS) as initially
described [5] and expanded upon by Olivera and Tei-
chert [9] using a-conotoxins as a model, demonstrates
the importance of understanding the phylogeny of the
Conoidea when targeting novel bioactive compounds.
Paramount to the strategy is the fact that the genes that
encode venom toxins are rapidly evolving, to reflect
changes in ecological niches. This ebb and flow between
genes and the surrounding environment results in a
diversification of toxins. One of the keys to understand-
ing this diversifying selection process is to reliably
reconstruct the phylogeny of the group and use it as a
roadmap for the discovery of peptide toxins with thera-
peutic applications.
5. Conclusion
The Terebridae are a promising family within the Con-
oidea. Similar to cone snails terebrids possess venom
peptide toxins that appear rich in variety and functional
applications (Table 1). Preliminary results conducting
biochemical [26] and molecular [27] characterization of
teretoxins indicate they are very similar in structure to
cone snail toxins. Teretoxins thus far identified appear
to be larger than conotoxins (≥ 40 amino acids) and do
not have posttranslation modifications, a feature com-
monly found in conotoxins. The lack of posttranslation
modifications makes teretoxins an attractive target for
analysis using mass spectrometry. Recently Ueberheide
and colleagues [47] developed a mass spectrometry
approach for elucidating toxin sequences from cone
snails that utilizes the electron-transfer dissociation
(ETD) method for tandem mass spectrometry. ETD is
used to increase sequence coverage and improve mass
detection to limits well beyond those of Edman
sequencing and previous mass spectrometry methods.
While limited by the current high cost of advanced
mass spectrometry hardware, this technique appears to
be a viable complement to the Concerted Discovery
Strategy (CDS), and can be used both to confirm the
expression and characterization of newly discovered ter-
etoxins. While thus far applied only to cone snail toxins,
the ETD inspired method also holds promise for identi-
fying the primary amino-acid sequences of peptide tox-
ins from terebrids and other venomous organisms. In
addition, recombinant techniques such as the recently
described tethered-toxin approach [48-51] facilitate the
synthesis and folding of larger peptidic toxins.
Although not traditionally the molecular compound of
choice for drug discovery, peptides, and especially pepti-
dic toxins, are becoming increasingly important in the
development of novel drug discovery pipelines. The N-
type calcium (Ca2+) channel analgesic ziconotide, the
first conotoxin drug, is striking for the molecular target
and function combination it identified [19]. Prior to
ziconotide’s discovery Ca2+ channels were not readily
recognized as targets for pain alleviation. Similar to
Ziconotide, an ω conotoxin, several other conotoxin
families including, μ-conotoxins, which target voltage-
gated Na+ channels, k- and kM-conotoxins, which target
K+ channels, and conantokins, which target NMDA
receptors, are under various stages of pharmaceutical
development [5,20,52]. The potential applications of
these conotoxins vary from pain, to epilepsy, and cardio-
protective agents. In addition to conotoxins, peptidic
toxins from scorpions, snakes and spiders, such as can-
doxin (Alzheimer’s disease) [53], and a-Bgtx (myasthe-
nic autoimmune response) [54,55] are making an impact
in pharmacological developments. These peptides and
the organisms that produce them are instrumental in
identifying the next generation of therapeutics.
A discovery strategy such as CDS, which takes into
account the divergent characteristic of peptide toxins
from biodiverse organisms, paired together with current
advances in peptide/proteomics, genomic and bioinfor-
matic technologies provides a paradigm for investigating
peptidic natural products that significantly enhances the
identification of pharmacologically useful bioactive com-
pounds. Current integrative initiatives that utilize ecolo-
gical, genomic, proteomic, and functional activity based
data of toxins, such as the cone snail genome project for
health, CONCO http://www.conco.eu, and Venomics
[56], will be useful in deciphering the potential and chal-
lenges ahead for terebrid toxin characterization.
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